Medical device company AngioDynamics Inc (NASDAQ:ANGO) said on Tuesday that Michael C. Greiner plans to step down as its executive vice president and chief financial officer (CFO).
In conjunction with the change, the company's senior vice president and general counsel Stephen A. Trowbridge will assume the role of interim chief financial officer in addition to his current responsibilities.
However, Greiner will remain with the company to facilitate a smooth transition of duties up to the filing of the second fiscal quarter 10-Q, and has initiated a process to determine a permanent successor.
Additionally, the company is reaffirming its previously issued financial guidance for fiscal year 2020.
Novocure announces presentation of new TTFields research at EANO and ESMO 2025 meetings
OSR Holdings to acquire Korean non-invasive glucose monitor developer Woori IO
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem